Fluocinonide
Corticosteroid — CARDIOVASCULAR SYSTEM
Also known as: flucetonide, fluocinolide, fluocinolide acetate, fluocinolone acetonide acetate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Fluocinonide is an ofp drug in the Corticosteroid class catalogued in DrugCentral. It was first approved by the FDA in 1971. Its mechanism of action is classified as Corticosteroid Hormone Receptor Agonists. DrugCentral lists 2 molecular targets, including NR3C1 and PGR. Recorded indications include Atopic dermatitis, Contact dermatitis, Discoid lupus erythematosus and Eruption of skin.
- Approval status: ofp (first approved 1971 by the FDA).
- Drug class: Corticosteroid.
- Mechanism of action: Corticosteroid Hormone Receptor Agonists.
- Molecular targets: NR3C1 and PGR (2 listed in DrugCentral).
- Indications: Atopic dermatitis, Contact dermatitis, Discoid lupus erythematosus, Eruption of skin and Granuloma annulare and others.
- ATC code: C05AA11 (Corticosteroids).
- Molecular formula: C26H32F2O7; molecular weight 494.53 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (13)
- Atopic dermatitis
- Contact dermatitis
- Discoid lupus erythematosus
- Eruption of skin
- Granuloma annulare
- Inflammatory dermatosis
- Lichen simplex chronicus
- Plaque psoriasis
- Primary cutaneous T-cell lymphoma
- Pruritus ani
- Pruritus of genital organs
- Scalp psoriasis
- Seborrheic dermatitis
Contraindications (5)
- Diabetes mellitus
- Hypercortisolism
- Hyperglycemia
- Hypopituitarism
- Infection of skin AND/OR subcutaneous tissue
Mechanism & targets
| Mechanism of action (MoA) | Corticosteroid Hormone Receptor Agonists |
|---|---|
| Established pharmacologic class | Corticosteroid |
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Glucocorticoid receptor | NR3C1 | agonist | Ki 8.62 |
| Progesterone receptor | PGR | unknown | Ki 8.54 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1971-06-30 | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C05AA11 | CARDIOVASCULAR SYSTEM › VASOPROTECTIVES › AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE › Corticosteroids |
D07AC08 | DERMATOLOGICALS › CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS › CORTICOSTEROIDS, PLAIN › Corticosteroids, potent (group III) |
D07CC05 | DERMATOLOGICALS › CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS › CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS › Corticosteroids, potent, combinations with antibiotics |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Psoriasis | 394.9 |
| Dermatitis atopic | 351.9 |
| Drug ineffective | 277.1 |
| Skin exfoliation | 227.8 |
| Pruritus | 188.8 |
| Rash | 143.8 |
| Skin plaque | 134.4 |
| Dry skin | 116.4 |
| Product dose omission issue | 108.9 |
| Eczema | 107.2 |
| Papule | 105.0 |
| Sleep disorder due to a general medical condition | 96.3 |
Chemical structure
| Molecular formula | C26H32F2O7 |
|---|---|
| Molecular weight | 494.53 g/mol |
| CAS number | 356-12-7 |
| InChIKey | WJOHZNCJWYWUJD-IUGZLZTKSA-N |
| PubChem CID | 91488 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Fluocinonide used for?
DrugCentral lists the following indications for Fluocinonide: Atopic dermatitis, Contact dermatitis, Discoid lupus erythematosus, Eruption of skin, Granuloma annulare, Inflammatory dermatosis, Lichen simplex chronicus and Plaque psoriasis and others.
How does Fluocinonide work?
Fluocinonide is classified as Corticosteroid Hormone Receptor Agonists; its molecular targets in DrugCentral include NR3C1 (agonist) and PGR.
When was Fluocinonide first approved?
Fluocinonide was first approved by the FDA in 1971.
What drug class does Fluocinonide belong to?
Fluocinonide is in the Corticosteroid class.
What is the chemical formula of Fluocinonide?
Fluocinonide has the molecular formula C26H32F2O7 and a molecular weight of 494.53 g/mol.
Browse: all drugs starting with F · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1205 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1201390 — compound record and bioactivity
- PubChem CID 91488 — chemical identifiers
- DrugBank DB01047 — drug record
- FDA UNII 2W4A77YPAN — substance identity
- DailyMed: FDA labels for Fluocinonide — current prescribing information (label search)
- UniProt P04150 (NR3C1) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.